criteria use omics-based predictors clinical trials
us national cancer institute nci collaboration scientists representing multiple areas expertise relevant omics-based test development developed checklist criteria can used determine readiness omics-based tests guiding patient care clinical trials checklist criteria cover issues relating specimens assays mathematical modelling clinical trial design ethical legal regulatory aspects funding bodies journals encouraged consider checklist may find useful assessing study quality evidence strength checklist will used evaluate proposals nci-sponsored clinical trials omics tests will used guide therapy
